ADH-1 trifluoroacetate

SKU: orb1308039

Description

ADH-1 trifluoroacetate (Exherin) is a cyclic pentapeptide that selectively inhibits N-cadherin, disrupting tumor vasculature and inducing apoptosis. It is used in cancer research for its antiangiogenic properties, studied in both in vitro models and in vivo xenograft experiments targeting N-cadherin-expressing tumors.

Research Area

Metabolism Research, Signal Transduction

Key Properties

• Target: Cadherin
• CAS Number: 1135237-88-5
• MW: 684.71
• Purity: 99.98% (May vary between batches)
• Formula: C₂₄H₃₅F₃N₈O₈S₂
• SMILES: OC(=O)C(F)(F)F.CC(C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(N)=O)NC(C)=O

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

ADH 1, ADH 1 Trifluoroacetate, ADH 1 trifluoroacetate, ADH1, ADH-1, ADH1 trifluoroacetate, ADH1 Trifluoroacetate, ADH-1 Trifluoroacetate, Exherin trifluoroacetate, Exherin Trifluoroacetate, Inhibitor, N-cadherin, inhibit

Compound Identifiers

PubChem CID

24203776